cholestyramine resin has been researched along with kanamycin a in 1 studies
| Studies (cholestyramine resin) | Trials (cholestyramine resin) | Recent Studies (post-2010) (cholestyramine resin) | Studies (kanamycin a) | Trials (kanamycin a) | Recent Studies (post-2010) (kanamycin a) |
|---|---|---|---|---|---|
| 2,669 | 342 | 190 | 7,169 | 187 | 946 |
| Protein | Taxonomy | cholestyramine resin (IC50) | kanamycin a (IC50) |
|---|---|---|---|
| 3-oxoacyl-[acyl-carrier-protein] synthase 3 | Escherichia coli K-12 | 6.8 | |
| Gap junction beta-2 protein | Homo sapiens (human) | 9.4 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andre, J | 1 |
1 other study(ies) available for cholestyramine resin and kanamycin a
| Article | Year |
|---|---|
[Role of bile salts in intestinal pathology].
Topics: Bile Acids and Salts; Biliary Tract Diseases; Celiac Disease; Cholestyramine Resin; Diarrhea; Humans; Intestinal Diseases; Kanamycin; Neomycin; Zollinger-Ellison Syndrome | 1974 |